China Resources Pharmaceutical Group (03320.HK): Tasly Pharmaceutical's net profit attributable to shareholders in the first half of the year was approximately 775 million yuan, a year-on-year increase of 16.97%.

The Economic Information APP reports that CR Pharmaceutical (03320.HK) has announced the performance of Tianji Medicine in the first half of 2025. The total operating income is approximately 4.288 billion yuan, a decrease of 1.91% year-on-year; the net profit attributable to shareholders of the listed company is approximately 775 million yuan, an increase of 16.97% year-on-year; and the basic earnings per share is 0.52 yuan.